Two-week interval optical coherence tomography: Imaging evidence on neointimal coverage completion after implantation of the endeavor zotarolimus-eluting stent

Catheterization and Cardiovascular Interventions

Volumn 82, Issue 7, 2013, Pages

  Nishinari, Makoto ^a   Shimohama, Takao ^a   Tojo, Taiki ^a   Shiono, Takaaki ^a   Shinagawa, Hisahito ^a   Kameda, Ryo ^a   Aoyama, Naoyoshi ^a   Izumi, Tohru ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

drug eluting stent; neointimal coverage; optical coherence tomography; zotarolimus

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; ZOTAROLIMUS;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FEMALE; HUMAN; IMAGE ANALYSIS; IMPLANTATION; JAPANESE; MALE; NEOINTIMA; OBSERVATIONAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; STABLE ANGINA PECTORIS; THICKNESS; THROMBOSIS; ZOTAROLIMUS ELUTING STENT;

DRUG-ELUTING STENT; NEOINTIMAL COVERAGE; OPTICAL COHERENCE TOMOGRAPHY; ZOTAROLIMUS;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR AGENTS; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; HUMANS; JAPAN; MALE; NEOINTIMA; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SIROLIMUS; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; WOUND HEALING;

EID: 84888132320     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25136     Document Type: Article

References (20)

1. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007; 356: 998-1008.
2. Guagliumi G, Sirbu V, Musumeci G, et al. Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: Findings from optical coherence tomography and intravascular ultrasound imaging. JACC Cardiovasc Interv 2012; 5: 12-20.
3. Finn AV, Joner M, Nakazawa G, et al. Pathological correlates of late drug-eluting stent thrombosis: Strut coverage as a marker of endothelialization. Circulation 2007; 115: 2435-2441.
4. Kandzari DE, Leon MB,. Overview of pharmacology and clinical trials program with the zotarolimus-eluting endeavor stent. J Interv Cardiol 2006; 19: 405-413.
5. Kim JS, Jang IK, Fan C, et al. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: The ENDEAVOR OCT trial. JACC Cardiovasc Interv 2009; 2: 1240-1247.
6. Yamaguchi T, Terashima M, Akasaka T, et al. Safety and feasibility of an intravascular optical coherence tomography image wire system in the clinical setting. Am J Cardiol 2008; 101: 562-567.
7. Takano M, Inami S, Jang IK, et al. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. Am J Cardiol 2007; 99: 1033-1038.
8. Kim JS, Jang IK, Kim JS, et al. Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: Comparison with sirolimus-eluting stents. Heart 2009; 95: 1907-1912.
9. Tanaka N, Terashima M, Rathore S, Itoh T, et al. Different patterns of vascular response between patients with or without diabetes mellitus after drug-eluting stent implantation: Optical coherence tomographic analysis. JACC Cardiovasc Interv 2010; 3: 1074-1079.
10. Terashima M, Kaneda H, Suzuki T, et al. The role of optical coherence tomography in coronary intervention. Kor J Intern Med 2012; 27: 1-12.
11. Tanigawa J, Barlis P, Di Mario C,. Intravascular optical coherence tomography: Optimization of image acquisition and quantitative assessment of stent strut apposition. Euro Interv 2007; 3: 128-136.
12. Chen BX, Ma FY, Luo W, et al. Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography. Heart 2008; 94: 566-570.
13. Kume T, Akasaka T, Kawamoto T, et al. Assessment of coronary arterial thrombus by optical coherence tomography. Am J Cardiol 2006; 97: 1713-1717.
14. Joner M, Nakazawa G, Finn AV, et al. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol 2008; 52: 333-342.
15. Collingwood R, Gibson L, Sedlik S, et al. Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model. Catheter Cardiovasc Interv 2005; 65: 227-232.
16. Fujii K, Kawasaki D, Oka K, et al. Endothelium-dependent coronary vasomotor response and neointimal coverage of zotarolimus-eluting stents 3 months after implantation. Heart 2011; 97: 977-982.
17. Virmani R, Kolodgie FD, Farb A, Lafont A,. Drug eluting stents: Are human and animal studies comparable? Heart 2003; 89: 133-138.
18. Kim JS, Fan C, Choi D, et al. Different patterns of neointimal coverage between acute coronary syndrome and stable angina after various types of drug-eluting stents implantation; 9-month follow-up optical coherence tomography study. Int J Cardiol 2011; 146: 341-346.
19. Jiménez-Valero S, Moreno R, Sánchez-Recalde A,. Very late drug-eluting stent thrombosis related to incomplete stent endothelialization: In-vivo demonstration by optical coherence tomography. J Invasive Cardiol 2009; 21: 488-490.
20. Gonzalo N, Serruys PW, Okamura T, et al. Optical coherence tomography patterns of stent restenosis. Am Heart J 2009; 158: 284-293.